Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An 'Omics' Perspective on Cardiomyopathies and Heart Failure.

Trends in molecular medicine - 1 Sept 2016

Raghow Rajendra

Abstract excerpt

Pathological enlargement of the heart, represented by hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM), occurs in response to many genetic and non-genetic factors. The clinical course of cardiac hypertrophy is remarkably variable, ranging from lifelong absence of symptoms to rapidly declining heart function and sudden cardiac death (SCD). Unbiased omics studies have begun to provide a glimpse...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiomyopathy, Dilated
Share to Cardiomyopathy, Hypertrophic
Share to Gene Expression Regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genomics

Share to Metabolomics

Share to Myocardium

Share to Polymorphism, Single Nucleotide

Share to Transcriptome

Source

Identifiers

PMID: 27499035
DOI: 10.1016/j.molmed.2016.07.007

Genes

SCD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An 'Omics' Perspective on Cardiomyopathies and Heart Failure.PMID 27499035Read ↗

Multi-Omic Architecture of Obstructive Hypertrophic CardiomyopathySemantic proximity Read ↗

Proteomic Characterisation of Heart Failure Reveals a Unique Molecular Phenotype for Hypertrophic CardiomyopathySemantic proximity Read ↗

Multi-Omics Profiling of Hypertrophic Cardiomyopathy Reveals Altered Mechanisms in Mitochondrial Dynamics and Excitation-Contraction Coupling.Semantic proximity Read ↗

Omics phenotyping in heart failure: the next frontierSemantic proximity Read ↗

Genotype-Phenotype Correlations in Inherited Cardiomyopathies, Their Role in Clinical Decision-Making and Implications in Personalized Cardiac Medicine in Multi-omics as Well as Disease Modelling ErasSemantic proximity Read ↗

The omics of channelopathies and cardiomyopathies: what we know and how they are usefulSemantic proximity Read ↗

404-Error “Disease Not Found”: Unleashing the Translational Potential of -Omics Approaches Beyond Traditional Disease Classification in Heart Failure ResearchSemantic proximity Read ↗

Where genome meets phenome: rationale for integrating genetic and protein biomarkers in the diagnosis and management of dilated cardiomyopathy and heart failure.Semantic proximity Read ↗

Heart Failure in the Era of Precision Medicine: A Scientific Statement From the American Heart AssociationSemantic proximity Read ↗

Cardiac Fibrosis in the Multi-Omics Era: Implications for Heart FailureSemantic proximity Read ↗

A Multi-Omics Atlas of Sex-Specific Differences in Obstructive Hypertrophic CardiomyopathySemantic proximity Read ↗

Integration of dilated cardiomyopathy genomics with transcriptomics from the human heart implicates regulatory molecular mechanismsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.